Harbin Medisan Pharmaceutical Co Ltd (002900) — Strategic Asset Allocation Index
Harbin Medisan Pharmaceutical Co Ltd (002900) has a Strategic Asset Allocation Index of 47.6% as of September 2023. Strategic assets (PP&E of CN¥1.02 Billion plus long-term investments of CN¥-) total CN¥1.02 Billion, measured against net assets of CN¥2.13 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See net asset quality index of Harbin Medisan Pharmaceutical Co Ltd to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Harbin Medisan Pharmaceutical Co Ltd Strategic Asset Allocation Index (2016–2021)
This chart shows how Harbin Medisan Pharmaceutical Co Ltd's Strategic Asset Allocation Index has evolved across 6 annual periods from 2016 to 2021. As of September 2023, the index stands at 47.6%, representing strategic assets of CN¥1.02 Billion against net assets of CN¥2.13 Billion CNY. For live market cap and overall valuation, see market cap of Harbin Medisan Pharmaceutical Co Ltd.
Annual Strategic Asset Allocation Index for Harbin Medisan Pharmaceutical Co Ltd (2016–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Harbin Medisan Pharmaceutical Co Ltd from 2016 to 2021, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See 002900 net asset value for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 43.7% | CN¥925.35 Million | CN¥925.35 Million | CN¥- | CN¥2.12 Billion | ▼ -4.7 pp |
| 2020 | 48.4% | CN¥867.29 Million | CN¥867.29 Million | CN¥- | CN¥1.79 Billion | ▲ +4.8 pp |
| 2019 | 43.6% | CN¥806.69 Million | CN¥806.69 Million | CN¥- | CN¥1.85 Billion | ▲ +6.7 pp |
| 2018 | 36.8% | CN¥725.71 Million | CN¥725.71 Million | CN¥- | CN¥1.97 Billion | ▼ -2.5 pp |
| 2017 | 39.3% | CN¥721.72 Million | CN¥721.72 Million | CN¥- | CN¥1.83 Billion | ▼ -50.1 pp |
| 2016 | 89.4% | CN¥722.60 Million | CN¥722.60 Million | CN¥- | CN¥808.17 Million | — |